| General Information of MET (ID: META00794) |
| Name |
Oxypurinol
|
| Synonyms |
Click to Show/Hide Synonyms of This Metabolite
1H,3H,9H-Alloxanthine; 1H-Pyrazolo[3,4-D]pyrimidin-4,6-diol; 4,6-Dihydroxypyrazolo[3,4-D]pyrimidine; Alloxanthine; Oxipurinol; Oxoallopurinol
|
| Source |
Endogenous;Drug Metabolite;Food;Drug
|
| Structure Type |
Purines and purine derivatives (Click to Show/Hide the Complete Structure Type Hierarchy)
Organoheterocyclic compounds
Imidazopyrimidines
Purines and purine derivatives
|
| PubChem CID |
|
| HMDB ID |
|
| Formula |
C5H4N4O2
|
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=4644"></iframe>
|
 |
|
3D MOL
|
2D MOL
|
|
Click to Show/Hide the Molecular/Functional Data (External Links/Property/Function) of This Metabolite
|
| KEGG ID |
|
| DrugBank ID |
|
| ChEBI ID |
|
| FooDB ID |
|
| ChemSpider ID |
|
| METLIN ID |
|
| Physicochemical Properties |
Molecular Weight |
152.1109 |
Topological Polar Surface Area |
N.A. |
| XlogP |
N.A. |
Complexity |
N.A. |
| Heavy Atom Count |
N.A. |
Rotatable Bond Count |
N.A. |
| Hydrogen Bond Donor Count |
N.A. |
Hydrogen Bond Acceptor Count |
N.A. |
| Function |
Oxipurinol is a xanthine oxidase inhibitor. Oxipurinol is potentially used for treatment of congestive heart failure. PMID: 15139781.
|
|
Regulatory Network
|
|
|
|
|
|
|
|
|